Lee S Cohen
Examiner (ID: 29, Phone: (571)272-4763 , Office: P/3739 )
| Most Active Art Unit | 3739 |
| Art Unit(s) | 0, 3739, 3794, 3736, 3305, 3311 |
| Total Applications | 3720 |
| Issued Applications | 3004 |
| Pending Applications | 173 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 390341
[patent_doc_number] => 07300937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-27
[patent_title] => 'Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication'
[patent_app_type] => utility
[patent_app_number] => 10/312195
[patent_app_country] => US
[patent_app_date] => 2001-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10020
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/300/07300937.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312195 | Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication | Oct 9, 2001 | Issued |
| 09/869468 | Immunosuppressive effects of pteridine derivatives | Oct 9, 2001 | Abandoned |
Array
(
[id] => 6131487
[patent_doc_number] => 20020077327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'
[patent_app_type] => new
[patent_app_number] => 09/967329
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12990
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077327.pdf
[firstpage_image] =>[orig_patent_app_number] => 09967329
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/967329 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Sep 27, 2001 | Abandoned |
Array
(
[id] => 6243544
[patent_doc_number] => 20020045751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Thyromimetic organic compounds'
[patent_app_type] => new
[patent_app_number] => 09/966960
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14504
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045751.pdf
[firstpage_image] =>[orig_patent_app_number] => 09966960
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/966960 | Thyromimetic organic compounds | Sep 27, 2001 | Issued |
Array
(
[id] => 951381
[patent_doc_number] => 06960585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-01
[patent_title] => 'Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same'
[patent_app_type] => utility
[patent_app_number] => 09/965977
[patent_app_country] => US
[patent_app_date] => 2001-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13814
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/960/06960585.pdf
[firstpage_image] =>[orig_patent_app_number] => 09965977
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/965977 | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same | Sep 26, 2001 | Issued |
Array
(
[id] => 6344242
[patent_doc_number] => 20020035127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Phenylalanine derivatives'
[patent_app_type] => new
[patent_app_number] => 09/964161
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23541
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035127.pdf
[firstpage_image] =>[orig_patent_app_number] => 09964161
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/964161 | Phenylalanine derivatives | Sep 25, 2001 | Abandoned |
Array
(
[id] => 1123887
[patent_doc_number] => 06794391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-09-21
[patent_title] => 'Derivatives of pyrimido6.1-aisoquinolin-4-one'
[patent_app_type] => B2
[patent_app_number] => 09/964260
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 13061
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/794/06794391.pdf
[firstpage_image] =>[orig_patent_app_number] => 09964260
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/964260 | Derivatives of pyrimido6.1-aisoquinolin-4-one | Sep 25, 2001 | Issued |
Array
(
[id] => 6451007
[patent_doc_number] => 20020177593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Agents and crystals for improving excretory potency of urinary bladder'
[patent_app_type] => new
[patent_app_number] => 09/960477
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37161
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177593.pdf
[firstpage_image] =>[orig_patent_app_number] => 09960477
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/960477 | Agents and crystals for improving excretory potency of urinary bladder | Sep 23, 2001 | Abandoned |
| 09/963129 | Quinazolino- and quinolino- guanidines as ligands for the neuropeptide FF (NPFF) receptors | Sep 23, 2001 | Abandoned |
Array
(
[id] => 6343964
[patent_doc_number] => 20020035092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Propanoic acid derivatives'
[patent_app_type] => new
[patent_app_number] => 09/955508
[patent_app_country] => US
[patent_app_date] => 2001-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39764
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035092.pdf
[firstpage_image] =>[orig_patent_app_number] => 09955508
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/955508 | Propanoic acid derivatives | Sep 17, 2001 | Abandoned |
Array
(
[id] => 6159005
[patent_doc_number] => 20020147192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Chemokine receptor binding heterocyclic compounds'
[patent_app_type] => new
[patent_app_number] => 09/957654
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43733
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147192.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957654
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957654 | Chemokine receptor binding heterocyclic compounds | Sep 16, 2001 | Issued |
Array
(
[id] => 5769341
[patent_doc_number] => 20060019974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => '4-Amino-quinazolines'
[patent_app_type] => utility
[patent_app_number] => 10/380908
[patent_app_country] => US
[patent_app_date] => 2001-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15748
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380908 | 4-amino-quinazolines | Sep 16, 2001 | Issued |
Array
(
[id] => 7474539
[patent_doc_number] => 20040097501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Triazole compounds useful as protein kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/953471
[patent_app_country] => US
[patent_app_date] => 2001-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87019
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097501.pdf
[firstpage_image] =>[orig_patent_app_number] => 09953471
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/953471 | Triazole compounds useful as protein kinase inhibitors | Sep 13, 2001 | Issued |
Array
(
[id] => 373388
[patent_doc_number] => 07473691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-06
[patent_title] => 'Pyrazole compounds useful as protein kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 09/952875
[patent_app_country] => US
[patent_app_date] => 2001-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86580
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/473/07473691.pdf
[firstpage_image] =>[orig_patent_app_number] => 09952875
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/952875 | Pyrazole compounds useful as protein kinase inhibitors | Sep 13, 2001 | Issued |
| 09/857345 | Methotrexate derivatives | Sep 11, 2001 | Abandoned |
Array
(
[id] => 1253582
[patent_doc_number] => 06670362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-30
[patent_title] => 'Pyridazine endothelin antagonists'
[patent_app_type] => B2
[patent_app_number] => 09/951019
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10183
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670362.pdf
[firstpage_image] =>[orig_patent_app_number] => 09951019
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/951019 | Pyridazine endothelin antagonists | Sep 11, 2001 | Issued |
Array
(
[id] => 6096797
[patent_doc_number] => 20020052356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Neuropeptide Y antagonists'
[patent_app_type] => new
[patent_app_number] => 09/939883
[patent_app_country] => US
[patent_app_date] => 2001-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14146
[patent_no_of_claims] => 145
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20020052356.pdf
[firstpage_image] =>[orig_patent_app_number] => 09939883
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/939883 | Neuropeptide Y antagonists | Aug 26, 2001 | Issued |
Array
(
[id] => 5788699
[patent_doc_number] => 20020161009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction'
[patent_app_type] => new
[patent_app_number] => 09/935288
[patent_app_country] => US
[patent_app_date] => 2001-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12284
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20020161009.pdf
[firstpage_image] =>[orig_patent_app_number] => 09935288
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/935288 | Use of selective antagonists of the α1B-adrenergic receptor for improvement of sexual dysfunction | Aug 21, 2001 | Issued |
Array
(
[id] => 6082609
[patent_doc_number] => 20020082271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases'
[patent_app_type] => new
[patent_app_number] => 09/934772
[patent_app_country] => US
[patent_app_date] => 2001-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16707
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082271.pdf
[firstpage_image] =>[orig_patent_app_number] => 09934772
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/934772 | Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases | Aug 21, 2001 | Issued |
Array
(
[id] => 1248757
[patent_doc_number] => 06673925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-06
[patent_title] => 'Method of producing thiobarbituric acid derivatives'
[patent_app_type] => B2
[patent_app_number] => 09/936330
[patent_app_country] => US
[patent_app_date] => 2001-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2818
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673925.pdf
[firstpage_image] =>[orig_patent_app_number] => 09936330
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/936330 | Method of producing thiobarbituric acid derivatives | Aug 19, 2001 | Issued |